Hiromi Muramatsu
Molecular Biology · 2008–2017
A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 22 citations into it; #7,234 of 17,773 by trust here, #6,216 by citations
Whom Hiromi Muramatsu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Hiromi Muramatsu overall
Papers from Hiromi Muramatsu's perspective
Ordered by how strongly the researchers Hiromi Muramatsu trusts endorse each paper. Same corpus, a different order for every researcher.
- 5'-Triphosphate RNA Is the Ligand for RIG-I
- AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma (Science)
- Highly efficient reprogramming to pluripotency and directed differentiation of human cells using synthetic modified mRNA (Cell Stem Cell)
- Recognition of single-stranded RNA viruses by Toll-like receptor 7. (Proceedings of the National Academy of Sciences of the United States of America)
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation (Nucleic Acids Research)
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice (Nature Biotechnology)
- Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
- A Toll-like receptor recognizes bacterial DNA (Nature)
- Toll-like receptors and innate immunity (Nature reviews. Immunology)
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction (Nature Biotechnology)
Their papers
- Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. (2008) — 1,650 citations
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes (2015) — 893 citations
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation (2010) — 616 citations
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA (2011) — 816 citations
- Zika virus protection by a single low dose nucleoside modified mRNA vaccination (2017) — 808 citations